Search research articles
Contact Us
Filters
Showing results (131-140 of 153) with videos related to
Page
of 16
Sort By:
Journal of Neuromuscular Diseases
|
April 26, 2016
The Angiotensin Converting Enzyme Inhibitor Lisinopril Improves Muscle Histopathology but not Contractile Function in a Mouse Model of Duchenne Muscular Dystrophy
Jeovanna Lowe, Andrew J Wodarcyk, Kyle T Floyd, et al.
Circulation. Heart Failure
|
October 8, 2009
Impairment of diastolic function by lack of frequency-dependent myofilament desensitization rabbit right ventricular hypertrophy
Kenneth D Varian, Anusak Kijtawornrat, Subash C Gupta, et al.
Frontiers in Physiology
|
November 19, 2019
Mineralocorticoid Receptor Signaling Contributes to Normal Muscle Repair After Acute Injury
J Spencer Hauck, Zachary M Howard, Jeovanna Lowe, et al.
Human Molecular Genetics
|
February 14, 2019
Mineralocorticoid receptor antagonists improve membrane integrity independent of muscle force in muscular dystrophy
J Spencer Hauck, Jeovanna Lowe, Neha Rastogi, et al.
Journal of Equine Veterinary Science
|
September 15, 2025
Morphometric parameters, metabolic profile and musculoskeletal alterations in Criollo horses competing in the morphology trial
Mariana A Mousquer, Cahuê F R Paz, Leandro A Rafael, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|
December 3, 2014
Claudin-5 levels are reduced from multiple cell types in human failing hearts and are associated with mislocalization of ephrin-B1
Sarah A Swager, Dawn A Delfín, Neha Rastogi, et al.
Journal of Molecular and Cellular Cardiology
|
February 1, 2023
The lack of Troponin I Ser-23/24 phosphorylation is detrimental to in vivo cardiac function and exacerbates cardiac disease
Hussam E Salhi, Vikram Shettigar, Lorien Salyer, et al.
Journal of Neuromuscular Diseases
|
July 17, 2018
Mineralocorticoid Receptor Antagonists in Muscular Dystrophy Mice During Aging and Exercise
Jeovanna Lowe, Feni K Kadakia, Jonathan G Zins, et al.
Molecular Therapy. Methods & Clinical Development
|
March 6, 2023
Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy model
Arden B Piepho, Jeovanna Lowe, Laurel R Cumby, et al.
ESC Heart Failure
|
September 18, 2020
Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy
Jeovanna Lowe, Peter Kolkhof, Michael J Haupt, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 153) with videos related to
Sort By:
Page
of 16
Journal of Neuromuscular Diseases
|
April 26, 2016
The Angiotensin Converting Enzyme Inhibitor Lisinopril Improves Muscle Histopathology but not Contractile Function in a Mouse Model of Duchenne Muscular Dystrophy
Jeovanna Lowe, Andrew J Wodarcyk, Kyle T Floyd, et al.
Circulation. Heart Failure
|
October 8, 2009
Impairment of diastolic function by lack of frequency-dependent myofilament desensitization rabbit right ventricular hypertrophy
Kenneth D Varian, Anusak Kijtawornrat, Subash C Gupta, et al.
Frontiers in Physiology
|
November 19, 2019
Mineralocorticoid Receptor Signaling Contributes to Normal Muscle Repair After Acute Injury
J Spencer Hauck, Zachary M Howard, Jeovanna Lowe, et al.
Human Molecular Genetics
|
February 14, 2019
Mineralocorticoid receptor antagonists improve membrane integrity independent of muscle force in muscular dystrophy
J Spencer Hauck, Jeovanna Lowe, Neha Rastogi, et al.
Journal of Equine Veterinary Science
|
September 15, 2025
Morphometric parameters, metabolic profile and musculoskeletal alterations in Criollo horses competing in the morphology trial
Mariana A Mousquer, Cahuê F R Paz, Leandro A Rafael, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|
December 3, 2014
Claudin-5 levels are reduced from multiple cell types in human failing hearts and are associated with mislocalization of ephrin-B1
Sarah A Swager, Dawn A Delfín, Neha Rastogi, et al.
Journal of Molecular and Cellular Cardiology
|
February 1, 2023
The lack of Troponin I Ser-23/24 phosphorylation is detrimental to in vivo cardiac function and exacerbates cardiac disease
Hussam E Salhi, Vikram Shettigar, Lorien Salyer, et al.
Journal of Neuromuscular Diseases
|
July 17, 2018
Mineralocorticoid Receptor Antagonists in Muscular Dystrophy Mice During Aging and Exercise
Jeovanna Lowe, Feni K Kadakia, Jonathan G Zins, et al.
Molecular Therapy. Methods & Clinical Development
|
March 6, 2023
Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy model
Arden B Piepho, Jeovanna Lowe, Laurel R Cumby, et al.
ESC Heart Failure
|
September 18, 2020
Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy
Jeovanna Lowe, Peter Kolkhof, Michael J Haupt, et al.
Page
of 16